Format

Send to

Choose Destination
Oncotarget. 2017 Sep 24;8(46):80103-80104. doi: 10.18632/oncotarget.21178. eCollection 2017 Oct 6.

Risk stratification in therapy-related myelodysplastic syndromes.

Author information

1
Section of Hematology, Department of Internal Medicine, Yale University, and Yale Comprehensive Cancer Center, New Haven, CT, USA.

KEYWORDS:

myelodysplastic syndromes; prognostic tools; therapy-related

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center